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iets and Cardiovascular Disease
n Evidence-Based Assessment
arin Parikh, BA,* Michael C. McDaniel, MD,† M. Dominique Ashen, PHD, CRNP,*
oseph I. Miller, MD,† Matthew Sorrentino, MD, FACC,‡ Vicki Chan, BS,*
oger S. Blumenthal, MD, FACC,* Laurence S. Sperling, MD, FACC*
altimore, Maryland; Atlanta, Georgia; and Chicago, Illinois
With rising obesity, despite low-fat diet recommendations, there is an increased interest in
weight loss and alternative dietary approaches for cardiovascular health. Physicians must have
an understanding of the literature to better counsel their patients about diets and cardiovas-
cular disease. This review examines several dietary approaches to cardiovascular health and
evaluates the available scientific evidence regarding these diets. (J Am Coll Cardiol 2005;45:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.11.0681379–87) © 2005 by the American College of Cardiology Foundation
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fietary advice regarding cardiovascular disease (CVD) pre-
ention is complex. Much confusion stems from the lack of
efinitive data on available diets and their potential health
enefits. For years, the American Heart Association (AHA)
as recommended a low-fat diet of 55% of total calories
rom carbohydrates, 30% from fat, and 15% from protein,
ith cholesterol restricted to 300 mg/day (1). However,
n unintended consequence of emphasizing this low-fat diet
ay have been to promote unrestricted carbohydrate intake
2).
The prevalence of obesity in America increased by 61%
ince 1991 (3). Each year, an estimated 300,000 U.S. adults
ie from obesity-related causes (4), and obesity plus physical
nactivity account for approximately 9.4% of U.S. health
are expenditures (5). Dietary improvement may signifi-
antly impact weight and cardiovascular morbidity. Due to
he increasing prevalence of obesity, despite low-fat recom-
endations, many new popular diets have emerged. Al-
hough some of these new diets may offer health benefits,
thers may potentially harm cardiovascular or overall health.
hysicians must have an understanding of these diets in
rder to counsel patients. The goal of this paper is to review
everal popular dietary approaches for cardiovascular health
nd evaluate the available scientific evidence behind these
iets.
ow-carbohydrate diets. A low-carbohydrate diet was first
haracterized by William Banting in the 1860s (6), but this
ype of diet has currently received much attention due to Dr.
tkins’ New Diet Revolution (7). The Atkins’ Diet recom-
ends two weeks of extreme carbohydrate restriction, fol-
owed by gradually increasing carbohydrates to 35 g/day.
he Atkins’ Diet has 68% of total calories from fat, 27%
From the *Department of Medicine, Johns Hopkins Ciccarone Preventive Cardi-
logy Center, Baltimore, Maryland; †Department of Medicine, Section of Preventive
ardiology, Emory University, Atlanta, Georgia; and the ‡University of Chicago,
epartment of Medicine, Section of Preventive Cardiology, Chicago, Illinois.5
Manuscript received September 19, 2004; revised manuscript received November
3, 2004, accepted November 29, 2004.rom protein, and 5% from carbohydrates (8). Other pop-
lar low-carbohydrate diets are summarized in Table 1.
Low-carbohydrate diets recommend limiting complex
nd simple sugars, causing the body to oxidize fat to meet
nergy requirements. During the initial carbohydrate re-
triction, the body resorts to ketosis for energy needs.
etones are excreted in the urine with fluid. Rapid initial
eight loss may be from this diuretic effect (8), which can be
ncouraging.
A drastic reduction in carbohydrates also leads to an
verall decrease in caloric intake (9). Even when calories are
ot actively restricted, low-carbohydrate dieters consume
ewer calories compared with baseline (10). Weight loss can
e sustained by this reduction in caloric intake. Although
alatable for the short term, low-carbohydrate diets raise
everal nutritional and cardiovascular concerns, as summa-
ized in Table 2.
Four randomized, controlled clinical trials (Table 3) have
ompared low-carbohydrate diets with low-fat diets (11–
5). Although the trials differed in design, all found an
verage of 4 to 6 kg greater weight loss in the low-
arbohydrate group at six months. However, the two studies
ollowed to one year showed no significant weight difference
11,12).
Foster et al. (11) conducted a randomized, controlled trial
asting one year. Sixty-three obese patients were assigned
ither a low-carbohydrate diet or a low-fat diet. The
ow-carbohydrate group showed greater weight loss at six
onths, but the weight loss between the groups was not
ignificant at one year. Low-carbohydrate dieters showed a
reater increase in high-density lipoprotein (HDL) choles-
erol and a decrease in triglycerides that was independent of
eight loss.
Stern et al. (12) conducted a one-year trial that followed
32 obese patients (body mass index 35 kg/m2). The
ubjects were randomized to a carbohydrate-restricted or
at-restricted diet. Average caloric intake decreased by
10 kcal/day in the low-carbohydrate group, but only by 97
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An Evidence-Based Review of Popular Diets May 3, 2005:1379–87cal/day in the low-fat group (p  0.183). At six months,
he low-carbohydrate group showed greater weight loss,
ncreased HDL cholesterol, decreased triglycerides, and
ncreased insulin sensitivity. At one year, there was no
ifference in weight loss between the two groups, although
hose on the low-carbohydrate diet continued to have lower
riglyceride and higher HDL cholesterol levels.
Brehm et al. (14) followed 53 female participants for six
onths in a randomized, controlled trial comparing a
ow-carbohydrate with a low-fat diet. Subjects met with a
ietitian every other week and had group meetings twice a
eek. At six months, the low-carbohydrate group showed
reater weight loss, increased HDL cholesterol, and de-
reased triglycerides.
Finally, Yancy et al. (15) conducted a six-month random-
zed, controlled trial of 120 overweight and hyperlipidemic
atients. The intervention group followed a low-
arbohydrate diet plus nutritional supplementation and
eceived exercise recommendations, and the control group
ollowed a low-fat diet. At six months, the low-
arbohydrate group lost more weight than the low-fat
roup, and their estimated daily energy intake was 41 kcal
ower. The low-carbohydrate group also had lower triglyc-
rides and higher HDL cholesterol. However, this analysis
s confounded by the nutritional supplements received by
he intervention group, such as fish oils, which decrease
riglyceride levels.
Bravata et al. (10) reviewed 94 low-carbohydrate diet
tudies. Weight loss in these studies was linked to caloric
estriction, diet duration, and initial baseline weight and
ge. However, there was no association between weight loss
nd carbohydrate restriction, suggesting that short-term
eight loss could instead be the result of caloric restriction
nd the ketosis-related diuretic effects. Of note, rapid, early
eight loss, as well as the palatable nature of a low-
arbohydrate diet, may act as motivating factors to remain
n this type of diet (14).
Although there is no consensus on what appropriate
ttrition rates for clinical trials of diets should be, attrition
ates of 24% to 39% (Table 4) point to the difficulty of
ollowing a low-carbohydrate diet over time. Only in one
Abbreviations and Acronyms
ALA  alpha-linolenic acid
CVD  cardiovascular disease
DASH  Dietary Approach to Stop Hypertension
DHA  docosahexaenoic acid
EPA  eicosapentaenoic acid
GI  glycemic index
GL  glycemic load
HDL  high-density lipoprotein
N3-FA  omega-3 polyunsaturated fatty acids
VLF  very low fatix-month trial (15) was the attrition rate in the low-
*
Aarbohydrate group significantly lower (p  0.05) than that
n the low-fat group.
Low-carbohydrate diets may increase HDL cholesterol,
ecrease triglyceride levels, and improve glycemic control,
ut there appears to be no significant difference in weight
oss compared with a low-fat diet at one year. Because the
ongest trial extends to one year with relatively few subjects,
ore studies are required to assess the efficacy of a low-
arbohydrate diet on long-term weight loss and cardiovas-
ular outcomes.
lycemic index diets. The glycemic index (GI) is a con-
ept that has been used in diets such as the South Beach
iet (16), Sugar Busters (17), and the Zone Diet (18).
hese diets allow carbohydrate consumption as long as they
ave a low GI. The GI is a measure of the blood glucose
esponse to intake of a particular carbohydrate (19). The
igher the peak in postprandial blood glucose levels, the
igher the GI value. The glycemic load (GL) is the product
f dietary GI and total dietary carbohydrate, providing a
seful measure of the total glycemic effect (20). Table 5
hows a list of common foods and their associated GI and
L. A high-GI diet has been proposed to increase hunger
nd elevate free fatty acid levels, leading to an increased risk
f obesity, diabetes, and CVD (21). Several in vitro exper-
ments indicate that elevated postprandial blood glucose
evels cause oxidative stress, leading to endothelial damage
nd activation of coagulation (22).
The framework of the South Beach Diet includes an
nitial two-week period of extreme carbohydrate restriction
ollowed by gradual re-introduction of low-GI carbohy-
rates. The maintenance phase encourages intake of fruits,
egetables, whole grains, mono- and polyunsaturated fats,
mega-3 fatty acids, nuts, and moderate dairy products.
nlike the Atkins’ Diet, the South Beach Diet encourages
able 1. Summary of Popular Low-Carbohydrate Diets*
he Atkins’ Diet
68% fat, 27% protein, 5% carbohydrates
35 g carbohydrate per day
rotein Power
54% fat, 26% protein, 16% carbohydrates
he Zone Diet
30% fat, 40% protein, 30% carbohydrates
Listed are the contents of three popular low-carbohydrate diets.
Adapted from data in reference 8.
able 2. Low-Carbohydrate Diet Pros and Cons*
Pros Cons
nitial weight loss High-protein diet
Diuretic effect
Palatable diet
Easier to maintain
Caloric restriction
Reason for weight loss?
Calcium balance
Renal and hepatic complications
Potentially atherogenic
High in saturated fat and
cholesterol
Low in fruits, vegetables, and whole
grainsThis table summarizes the positive and negative aspects of low-carbohydrate diets.
dapted from data in references 7–10.
l
a
r
T
d
a
p
o
h
i
w
d
r
f
P
f
f
p
d
r
d
w
s
h
(
1
d
a
N
f
s
0
f
G
b
o
p
d
t
s
d
V
l
d
u
d
t
s
d
t
c
s
o
i
v
t
2
c
w
c
t
1
fi
c
P
c
d
T
L
L
L
L
L
p
*
D , 14,
1381JACC Vol. 45, No. 9, 2005 Parikh et al.
May 3, 2005:1379–87 An Evidence-Based Review of Popular Dietsean protein, such as fish and poultry, and allows olive oil as
source of mono- and polyunsaturated fat.
The longest interventional study conducted in humans
elated to GI was a crossover study lasting 12 weeks (23).
hirty women were randomized to a low-GI or high-GI
iet. Those on a high-GI diet lost 7.4 kg, whereas those on
low-GI diet lost 9.4 kg (p  0.14). In 16 women who
articipated in a 12-week follow-up, crossover study, those
n a low-GI diet lost 7.4 kg, compared with 4.5 kg on a
igh-GI diet (p  0.05). However, the results from other
nterventional studies, although shorter in duration and
ith smaller populations, have been inconsistent (24).
A possible association between a high-GI diet and
iabetes has been observed. Studies that investigated this
elationship include the Nurses’ Health Study (25), which
ollowed over 65,000 U.S. women for six years, the Health
rofessionals’ Survey (26), which followed 42,750 U.S. men
or six years, and the Iowa Women’s Health Study, which
ollowed 36,000 women for six years (27). All of these
rospective cohort studies showed an association between
iabetes and high GL. A recent meta-analysis of 14
andomized, controlled trials comparing low- and high-GI
iets in diabetes management showed that glycated proteins
ere reduced 7.4% on a low-GI diet (28). Multiple cohort
tudies (Table 6) have been inconclusive as to whether a
igh-GI diet may also be linked to CVD risk factors
29–33).
High-GI diets may alter HDL metabolism. A survey of
,420 British adults (32) evaluated GI through a seven-day
iet survey and showed an inverse relationship between GI
nd HDL cholesterol. The Third National Health and
utrition Examination Survey (NHANES III) (33), which
ollowed 13,907 subjects older than 20 years old, demon-
trated that for every 15-U increase in GI, there was a
.06-mmol/l decrease in HDL cholesterol.
Many of these prospective cohort studies contain con-
ounding variables. Most of these studies based their GI and
able 3. Low-Carbohydrate Diet and Weight Loss*
Foster et al. (11)
ength of trial 12 months
ow-CHO baseline weight (kg) 99  20
ow-CHO diet weight change (kg) 4%  7%†
ow-fat baseline weight (kg) 98  16
ow-fat diet weight change (kg) 3%  6%†
Value (between groups) 0.26
This table summarizes the four large randomized, controlled trials effects on weight l
ata are presented as the mean value  SD. Adapted from data in references 11, 12
CHO  carbohydrate.
Table 4. Attrition Rates in Randomized, Cont
Attrition Rate† Foster et al. (11) Stern
Low-carbohydrate diet 39% (12 months) 33%
Low-fat diet 43% (12 months) 47%
*This table summarizes the attrition rates for the low-carboh
investigating low-carbohydrate diets. †The attrition rate was signific
data in references 11, 12, 14, and 15.L calculations on self-reporting. Portion size and recall
ias could result in inaccurate reporting (24). Also, the GI
f a food can change depending on the method of food
reparation and different types of the same food (i.e.,
ifferent grains of rice). Despite suggestive evidence, no
rials have shown that low-GI diets prevent CVD. Longer
tudies with more participants are needed before low-GI
iets can be definitively recommended.
ery-low-fat (VLF) diets. Very-low-fat (VLF) diets allow
ess than 15% of total calories from fat (with an equal
istribution of saturated, monounsaturated, and polyunsat-
rated fats), 15% from protein, and 70% from carbohy-
rates. The VLF diet includes variations of vegetarian diets
hat may include eggs and dairy. Although an AHA
cientific statement concluded there were little long-term
ata to suggest that low-fat diets alone will sustain long-
erm weight loss, there is evidence that this diet can impact
ardiovascular risk (34).
The Heidelberg trial (35) evaluated 113 patients with
table angina. The experimental group reduced fat to20%
f calories and total cholesterol to200 mg/dl and engaged
n moderate-intensity exercise. After 12 months, the inter-
ention group’s body weight decreased by 5% (p  0.001),
otal cholesterol by 10% (p  0.001), and triglycerides by
4% (p  0.001). In the intervention group, progression of
oronary lesions by angiography was decreased compared
ith that of controls (p  0.05). However, given the
onfounding effects of exercise, this study makes it difficult
o assess the effects of diet alone.
The Pritikin diet recommends10% of calories from fat,
5% to 20% from protein, and the remainder from unre-
ned, complex carbohydrates. In a small three-week study
ombining statins, diet, and vigorous exercise, those on the
ritikin diet resulted in a further 19% reduction in total
holesterol. There was also an incremental benefit in low-
ensity lipoprotein (LDL) cholesterol and triglycerides for
ern et al. (12) Brehm et al. (14) Yancy et al. (15)
12 months 6 months 6 months
130  23 91  8 97  19
5  9† 9  1.0† 12  2†
132  27 92  6 98  15
3  8† 4  1.0† 7  2†
0.195 0.001 0.001
d the duration of each trial. †p  0.05 for difference from baseline within the group.
and 15.
Trials*
l. (12) Brehm et al. (14) Yancy et al. (15)
onths) 27% (6 months) 24%* (6 months)
onths) 52% (6 months) 43%* (6 months)
and low-fat dieters in the four randomized, controlled trialsSt
oss anrolled
et a
(12 m
(12 m
ydrate
antly different between two groups (p 0.02). Adapted from
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An Evidence-Based Review of Popular Diets May 3, 2005:1379–87hose on the diet, but also a slight reduction in HDL
holesterol (36).
The Ornish Lifestyle Heart Trial (37) randomized 48
atients with moderate to severe coronary heart disease
CHD) to intensive life-style changes or usual care. The
ntensive life-style changes included a vegetarian diet with
% of caloric intake coming from fat, moderate aerobic
xercise, stress management training, smoking cessation,
nd group psychosocial support. A total of 195 coronary
rtery lesions were analyzed angiographically. Overall, 82%
f experimental group patients had an average change
oward lesion regression. At five years, there were 2.5 times
ewer cardiac events in the intervention group, and the
verage percent diameter stenosis showed an 8% decrease in
iameter, whereas the control group had 28% progression.
owever, the data are difficult to interpret due to the
onfounding effects of exercise, stress reduction, and 11-kg
eight loss in the intervention group. Although the inter-
ention seems beneficial, the small sample size and intense
ife-style changes raise concerns about the universal sustain-
bility of such a program.
The VLF diet and intense life-style changes have signif-
cant results in terms of reducing risk factors and cardiac
vent rates. However, these studies are relatively small, and
he programs involved may be influenced by selection bias.
he programs require a motivated group of patients to
able 5. Glycemic Index and Glycemic Loads of Various Foods*
Food Glycemic Index Glycemic Load
lucose 100 —
ornflakes 92 24
aked potato 85 26
nstant rice 75 28
hite bread 70 10
oca-cola 63 16
heat bread 52 10
arrot 47 3
paghetti 41 20
pple 40 6
entil beans 29 5
eanuts 13 1
This table shows the glycemic index and glycemic load of various foods compared
ith glucose. Adapted from data in reference 21.
able 6. Cohort Studies Investigating Low-Glycemic Index and
Cohort Population Interve
urse’s Health Study (29) 75,521 women GL
utphen Elderly Study (30) 646 Dutch men GI
talian case-control study (31) 881 Italians post-acute MI GI and
ritish adult survey (32) 1,420 British adults GI
HANES III (33) 13,907 U.S. adults GI
This table summarizes the results of five large cohort studies investigating the glycemi
nd the results. Adapted from data in references 29–33.
CHD  coronary heart disease; GI  glycemic index; GL  glycemic load; HDL ndergo rigorous life-style adjustments. The VLF diet may
e unnecessary if other life-style characteristics like exercise,
moking cessation, and stress management are optimized.
he Mediterranean Diet. The Mediterranean Diet is
haracterized by (38): 1) an abundance of plant food (fruit,
egetables, breads, cereals, potatoes, beans, nuts, and seeds);
) minimally processed, seasonally fresh, locally grown
oods; 3) desserts comprised typically of fresh fruit daily and
ccasional sweets containing refined sugars or honey; 4)
live oil (high in polyunsaturated fat) as the principal source
f fat; 5) daily dairy products (mainly cheese and yogurt) in
ow to moderate amounts; 6) fish and poultry in low to
oderate amounts; 7) up to four eggs weekly; 8) red meat
arely; and 9) and wine in low to moderate amounts with
eals.
Although a Mediterranean-style diet has demonstrated
reater weight reduction compared with control diets in
andomized, controlled trials (39), the most impressive
enefits of the diet are related to cardiovascular morbidity
nd mortality. No isolated aspect of the Mediterranean Diet
xplains these benefits, but much has focused on the
mega-3 polyunsaturated fatty acids (N-3 FA). Examples of
-3 FA include eicosapentaenoic acid (EPA) and docosa-
exaenoic acid (DHA) found in fatty fish like salmon,
ackerel, herring, and trout (40). A form of N-3 FA
erived from plants—alpha-linolenic acid (ALA)—is found
n nuts, canola (rapeseed) oil, flaxseed, flaxseed oil, and
oybean oil (40). Alpha-linolenic acid can be converted to
PA and DHA (41), which are thought be cardioprotective
41–46).
One major mechanism of protection may be related to the
nti-arrhythmic effects of N-3 FA (47). Data from various
nimal, epidemiologic, and metabolic studies, as well as
maller clinical trials, demonstrate the benefits of N-3 FA in
educing the risk of sudden cardiac death (48). Omega-3
olyunsaturated fatty acids also decrease the arachidonic
cid content of cell membranes, reduce eicosanoids, down-
egulate gene expression of adhesion molecules, and inhibit
he synthesis of proinflammatory cytokines such as tumor
ecrosis factor-alpha, interleukin (IL)-1, and IL-2 (49).
oreover, fish oil supplements can lower triglycerides,
iovascular Disease Risk*
Follow-Up Results
10 yrs GL directly associated with risk of CHD
10 yrs GI showed no correlation to CHD, total
cholesterol levels, HDL cholesterol,
triglycerides
4 yrs No association between GL or GI with acute
MI risk
Cross-sectional Negative relation between GI of diet and serum
HDL cholesterol
Cross-sectional Decrease of 0.06 mmol/l of HDL cholesterol
for every 15-U increase in glycemic index
and glycemic load. Included are the length of each study, the number of participants,Card
ntion
GL
c indexhigh-density lipoprotein; MI  myocardial infarction.
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May 3, 2005:1379–87 An Evidence-Based Review of Popular Dietsnhibit endothelial cell activation, and improve endothelial
unction in diabetics (50). They can also reduce platelet
ggregation (51) and decrease the heart rate (52).
Multiple randomized, controlled trials have demonstrated
he benefits of the Mediterranean Diet on secondary pre-
ention of CVD (Table 7) (53–57). The Diet and Rein-
arction Trial (DART) (49) followed 2,000 men for two
ears to study the effect on the secondary prevention of
yocardial infarction (MI). The men were randomized to
our groups. One group received advice in accordance with
HA dietary guidelines. Another group was advised to
onsume fish twice per week (300 g total) in order to achieve
pproximately 2.5 g of EPA weekly. A third group was told
o increase cereal fiber intake to 18 g/day. A fourth group
controls) did not receive advice. In comparing the four
roups, the fish group showed a 29% reduction in mortality
ompared with the control group. The rate of fatal MI was
lso less in the fish group.
The Lyon Diet Heart Study (56) randomized 605 par-
icipants with a previous MI for 46 months and showed an
nverse relationship between ALA intake and the risk of a
econd MI. The intervention group was advised to eat more
sh, fruits, and vegetables and to use an ALA-rich marga-
ine. The control group was advised to follow a prudent diet.
here was a 68% decrease in primary end points (cardiac
eath and nonfatal MI). Secondary end points (periproce-
ural infarctions, unstable angina, heart failure, stroke, and
ulmonary or peripheral embolisms) also decreased. Of
ote, at four-year follow-up, most experimental patients
ere still closely following the recommended diet.
The largest randomized, controlled trial examining the
enefits of fish oil supplements was the GISSI-Prevenzione
rial (57), which followed 11,234 subjects for a mean of 42
able 7. Summary of Randomized, Controlled Trials With Medi
Study Patients Enrolled
Follow-Up
Time Cont
ART (55) 2,033 Post-MI men 2 yrs No die
ndian Experiment of
Infarct Survival (53)
360 Post-acute MI 1 yr Placebo
yon Diet Heart (56) 605 Post-MI 46 months Pruden
Wes
diet
ndo-Mediterranean
Diet (54)
1,000 2 yrs Step I
ISSI-Prevenzione (57) 11,324 Post-MI 3.5 yrs Placebo
This table summarizes five randomized, controlled trials investigating the Mediterran
he control diet in study, the experimental diet, and the results of the study. Adapte
ALA  alpha-linolenic acid; CV  cardiovascular; EPA  eicosapentaenoic acionths. Participants were randomized to four groups, with Dubjects receiving a placebo, fish oil supplements equivalent
o 1 g of EPA/DHA per day, 300 mg of vitamin E per day,
r both the fish oil supplements and vitamin E. The
nvestigators found no effect of vitamin E on CVD. In the
xperimental group, there was an approximate 20% reduc-
ion over 3.5 years in cardiac death, nonfatal MI, and
onfatal stroke. The greatest benefit was seen in sudden
ardiac death, with reductions of 35% to 45%.
Multiple prospective cohort studies (Table 8) support the
enefit of a Mediterranean-style diet (58–60). Most re-
ently, 22,043 patients from a Greek population completed
questionnaire for the European Prospective Investigation
nto Cancer and Nutrition (61). Investigators used a scale of
to 9 to estimate adherence to the Mediterranean Diet,
ith higher scores reflecting greater adherence. After a
ean follow-up of 44 months, each two-point increment in
dherence to the diet was associated with a 25% reduction in
otal mortality. Greater compliance was associated with
eductions in CHD and cancer mortality. This study points
o the possible synergistic effect of the Mediterranean Diet
s a whole, rather than protective effects of any one aspect.
There is consistent basic science and clinical trial evidence
or the cardioprotective effects of the Mediterranean Diet,
articularly in secondary prevention of acute and fatal MI.
atients on a Mediterranean diet have been shown to lose
ore weight, have lower C-reactive protein levels, have less
nsulin resistance, have lower total cholesterol and triglyc-
ride and higher HDL levels, and have a decreased preva-
ence of the metabolic syndrome (39). Although attrition
ata are not available for all the trials, the Lyon Diet Heart
rial concluded most experimental patients were still closely
ollowing the recommended diet at four years (56). The
HA guidelines recommend consuming 1 g/day of EPA/
nean-Style Diets*
iet Experimental Diet Results
dvice Fatty fish twice per week with
goal of 500–800 mg/day of
N-3 fatty acids
29% reduction in all-cause
mortality, 27% decrease in
fatal MI
EPA supplement or ALA
supplement
EPA: 50% decrease in cardiac
death, 48% decrease in
nonfatal MI ALA: 40%
decrease in cardiac events
tyle
Mediterranean diet rich in
fish, fruits, vegetables, and
ALA margarine
68% decrease in cardiac death
and nonfatal MI; protective
effects lasted 4 years
P Mediterranean style (fruits,
grains, vegetables, mustard
seed or soy bean oil, and
walnuts)
Significant reduction in
sudden cardiac death and
nonfatal MI
1 g/day omega-3 fatty acid
fish-oil supplements
20% decrease in mortality,
30% decrease in CV
deaths, 46% decrease in
sudden deaths
tyle diet. The table lists the number of patients randomized, the length of follow-up,
data in references 53–57.
 myocardial infarction; NCEP  National Cholesterol Education Program.terra
rol D
tary a
t
tern-s
NCE
ean-sHA; however, it is quite difficult to sustain this level with
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An Evidence-Based Review of Popular Diets May 3, 2005:1379–87sh consumption alone (40). Based on the GISSI trial, the
HA and others (62) have therefore recommended taking
upplements of three 1-g fish oil capsules per day.
In regard to primary prevention, studies show that a
editerranean diet may be linked to decreased rates of
udden cardiac death, CHD, and possibly overall mortality.
systematic review by Hu and Willet (52) of metabolic,
pidemiologic, and clinical trial evidence indicated that
hree dietary strategies are effective in preventing CHD: 1)
ubstituting non-hydrogenated unsaturated fats for satu-
ated and trans-fats; 2) increasing consumption of omega-3
atty acids; and 3) consuming more fruits, vegetables, nuts,
nd whole grains, while avoiding refined grain products.
There are some concerns regarding the Mediterranean
iet. Potential side effects of the diet include a fishy
ftertaste, gastrointestinal discomfort, and possibly an in-
rease in LDL cholesterol (40). Another concern is mercury
xposure. In fact, the Food and Drug Administration
FDA) currently recommends that children and women
ho are pregnant and/or lactating should avoid fish con-
umption (40).
ietary Approaches to Stop Hypertension (DASH).
he DASH Diet is similar to a Mediterranean-type diet,
mphasizing high intake of fruits, vegetables, low-fat dairy
roducts, whole grains, nuts, fish, and poultry, as well as
educing total and saturated fats. Reduced intake of red
eat, sweets, and sugar-containing beverages is encouraged,
hich results in a diet high in potassium, calcium, magne-
ium, and fiber. This dietary approach has been shown to
ower blood pressure, but little has been published regarding
eight loss.
The original DASH trial (63) consisted of 459 subjects
ith systolic blood pressures 160 mm Hg and diastolic
lood pressures between 80 and 95 mm Hg. For three
eeks, all participants were fed a control diet low in fruits,
egetables, and dairy products, and with a fat content typical
f an American diet (37% of daily caloric intake). During
he following eight weeks, the participants were randomized
o one of three diets: the control diet, a diet rich in fruits and
egetables, or the DASH Diet.
able 8. Large Prospective Cohort Studies Investigating the Med
Cohort Population Interv
urse’s Health Study (58) 84,688 women Fish and N3-F
hysicians’ Health Study (59) 20,551 men Blood levels of
ardiovascular Health Study (60) 5,201 65 years old Plasma N3-FA
uropean Prospective
Investigation into Cancer and
Nutrition (61)
22,043 Greeks Mediterranean
This table summarizes the results of four large cohort studies examining the Medit
ollow-up, and the results. Adapted from data in references 58–61.
DHA  docosahexaenoic acid; N3-FA  omega-3 polyunsaturated fatty acids; oThe DASH Diet reduced systolic blood pressure by 5.5 cm Hg and diastolic blood pressure by 3.3 mm Hg, as
ompared with controls. Subgroup analysis showed that
frican Americans and those with hypertension had the
reatest reduction in blood pressure. The DASH diet results
ight be applied to a larger group due to the heterogeneous
opulation: half of the participants were women, 60% were
frican American, and 37% had household incomes of
$30,000 per year. One limitation of applying the DASH
iet to the general population is that the study was carried
ut in a very controlled setting, where all the meals were
repared for the subjects, and thus no comments may be
ade regarding attrition rates for the diet.
The DASH Diet was not low in sodium, but still reduced
lood pressure. A meta-analysis of 56 randomized, con-
rolled trials that included over 3,500 participants did not
upport universal sodium restriction, but instead only rec-
mmended dietary sodium restriction in the elderly (64).
To further investigate the effects of sodium restriction,
he DASH-Sodium Trial (65) was conducted. A total of
12 subjects were randomized to the control diet or DASH
iet for 90 days. Within each arm, patients were further
tratified and assigned to three diets: high (3.5 g/day),
ntermediate (2.3 g/day), or low (1.2 g/day) sodium, each
or a 30-day period in a random order. In the control group,
here was a dose response with the greater reductions in
odium intake correlating with greater decreases in blood
ressure. For those on the DASH Diet, the dose response
ersisted, although the effects of sodium reduction were
maller. Additionally, there was no significant difference
etween high and intermediate sodium intake on diastolic
lood pressure for those on the DASH Diet. The difference
as only significant between the high- and low-sodium
roups. The DASH Diet can reduce systolic blood pressure
y 5.5 mm Hg and diastolic blood pressure by 3.3 mm Hg.
owever, the effect of sodium reduction on hypertension
emains controversial. Lowering sodium to the levels of 1.2
/day, as achieved in the lowest sodium intake group of the
ASH-Sodium Trial, would be nearly impossible without
hanges in the food industry, as 75% of sodium intake
anean Diet*
n Follow-Up Results
sumption 16 yrs High consumption of fish (five times a week)
cuts the risk of dying from CHD by 45%,
compared with women who rarely ate fish
A 17 yrs Relative risk of sudden death lower among
men with higher blood levels of N3-FA
7 yrs Higher concentration of EPA, DHA, or
ALA associated with lower risk of fatal
ischemic heart disease
scale 44 months Two-point increase in adherence with
Mediterranean Diet associated with 25%
reduction in total mortality
an Diet. Included are the number of participants in the study, the intervention, the
bbreviations as in Tables 6 and 7.iterr
entio
A con
N3-F
Diet
erraneomes from additions made in processing (66).
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earching for optimal methods to lose weight and maintain
diet that sustains cardiovascular health. Patient frustration
ith current AHA and National Cholesterol Education
rogram (NCEP) low-fat guidelines has been evident by
oor compliance to these recommended diets and the
ncreasing prevalence of obesity. The scientific community
as also begun to question the low-fat diet–heart hypothesis
67). A few summary points (Table 9) can be extracted from
his review.
igure 1. The Mayo Clinic Healthy Weight Pyramid is a tool to help lose
o healthy eating compared with the USDA Food Guide Pyramid. It focus
mount of food. The foundation of the pyramid is unlimited amounts of v
quals 25 calories; one serving of fruit equals 60 calories. Level two in the p
ne serving of carbohydrate equals 70 calories. Protein/dairy is the third
able 9. Diet Summary Points
ow-Carbohydrate Diet
Short-term weight loss
Long-term effects on CVD unknown
Guide to initiate decreased energy intake
lycemic Index and Diet
Unproven effects on CVD
Guide to decreased consumption of energy-dense carbohydrates and
initiate weight loss
ery-Low-Fat Diet
Possible decrease in cardiac events
Concerns about universal applicability and sustainability
editerranean Diet
Secondary prevention
Prevention of sudden cardiac death
Healthy overall approach to dieting
Long-term sustainability
ASH
Decreased hypertension
Similar to Mediterranean Diet
VD  cardiovascular disease.alories. Fats, the fourth level of the pyramid, include heart-healthy olive oil, n
f fat equals 45 calories.A low-carbohydrate diet can lead to short-term weight
oss. However, the long-term effects on CHD risk factors,
uch as weight loss, HDL and LDL cholesterol, triglycer-
des, glycemic control, and blood pressure, are unknown.
Moderate-sized studies on VLF diets show decreases in
ardiovascular events, but the sustainability and applicability
f these diets to a large population is a concern. Moreover,
s many of these studies also included life-style changes as
art of the treatment, it is not possible to separate these
ffects from those of the diet itself.
No adequate randomized, controlled trials have evaluated
he effects of a low-GI diet on CVD. Nonetheless, diets
ased on a low GI, such as the South Beach Diet, can
ncourage consumption of mono- and polyunsaturated fats,
ean protein, fruits, vegetables, and whole-grain foods in-
tead of simple, refined carbohydrates.
The Mediterranean Diet has been shown to be cardio-
rotective in both prevention of sudden cardiac death and
econdary prevention.
The DASH Diet, which has shown to reduce blood
ressure, fits well into the framework of a Mediterranean
iet and can help decrease the cardiovascular risk of
ypertension.
Although none of the reviewed diets are independently
erfect for weight loss and cardiovascular health, an optimal
iet can be extracted from this review. Specifically, such a
iet would encourage: 1) decreased carbohydrate intake,
specially of refined and high-GI carbohydrates; 2) in-
reased consumption of fruits, vegetables, and whole grains;
ht or maintain weight. The pyramid offers a somewhat different approach
low energy-dense foods, which have a small number of calories in a large
les and fruits (minimum four servings per day). One serving of vegetables
d is carbohydrates, including whole grains (four to eight servings per day).
of the pyramid (three to seven servings per day). One serving equals 70weig
es on
egetab
yrami
leveluts, canola oil, and avocados (three to five servings per day). One serving
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onsumption of plant oils and fish; 4) and moderate intake
f low-fat dairy products and nuts.
Although many patients desire quick weight loss, patients
hould understand the basic concept that food is fuel, and
eople will lose weight if they burn more calories than they
onsume. Just as patients should not restrict fat and eat
nrestricted amounts of carbohydrates, patients should not
ecrease carbohydrates and eat unrestricted amounts of fat.
ortion size and total caloric intake is often more important
han individual foods.
In place of the traditional USDA food pyramid, the
ayo Clinic has published an alternative healthy weight
ood pyramid (Fig. 1) (68). This pyramid illustrates an
pdated version of a properly balanced diet and promotes a
ealthy and sustainable dietary change instead of relying on
hort-term diets (69), recommendations supported by the
vidence presented in this review. By encouraging patients
o adopt an active lifestyle and to lose weight gradually using
n evidence-based dietary approach, physicians can better
ounsel patients toward improved cardiovascular health.
eprint requests and correspondence: Dr. Laurence Sperling,
he Emory Clinic, 1525 Clifton Road, Suite 214, Atlanta,
eorgia 30322. E-mail: Laurence_Sperling@emoryhealthcare.org.
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